Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.9400
0.00 (0.00%)
At close: Jul 3, 2025, 1:00 PM
0.9670
+0.0270 (2.87%)
After-hours: Jul 3, 2025, 4:57 PM EDT
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $28.29 million as of July 3, 2025. Its market cap has decreased by -50.89% in one year.
Market Cap
28.29M
Enterprise Value
26.00M
1-Year Change
-50.89%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $28.29M, a decrease of -70.16%. That is a compound annual growth rate of -17.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 28.30M | -45.37% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |